Apnimed Inc. (APMD)
APMD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$17.83
-4.29% on the day
Market cap
$742.3M
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | APMD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0001745648 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-07-31 |
| Latest quarterly / interim | 10-Q | 2026-09-08 |
| Latest current report | 8-K | 2026-09-08 |
Source: SEC EDGAR submissions feed, 54 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.9% |
| 1 month | -32.1% |
| 3 months | Not enough price history |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -46.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OBX | Obsidian Therapeutics Inc. | $11.99 | -6.25% | $740.7M |
| GYRE | Gyre Therapeutics Inc. | $6.71 | -2.26% | $748.2M |
| ANL | Adlai Nortye Group Ltd. | $11.76 | -17.34% | $757.0M |
| ANNX | Annexon Inc. | $3.83 | -3.28% | $726.1M |
| IMMX | Immix Biopharma Inc. | $8.69 | -6.05% | $720.4M |
| HELP | Helus Pharma Inc. | $10.50 | -4.80% | $767.1M |
| LXRX | Lexicon Pharmaceuticals Inc. | $1.61 | -2.42% | $716.4M |
| GERN | Geron Corporation | $1.20 | -1.64% | $771.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier